Claro Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,725
Closed -$221K 287
2022
Q1
$221K Buy
+8,725
New +$387K 0.08% 247

Other funds holding BME

Claro Advisors's BME Position: Q2 2022 in Review

Claro Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2022, closing a stake of 8,725 shares — an estimated $221K sold.

Claro Advisors first reported a position in BME in Q1 2022 and held it in 1 quarter. The position peaked at $221K in Q1 2022. 62 funds tracked by Wall St. Rank hold BME as of Q2 2022.

  • Claro Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2022 after selling out during the quarter.
  • Claro Advisors sold 8,725 BlackRock Health Sciences Trust shares in Q2 2022, an estimated $221K.
  • Claro Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 1 quarter.
  • Claro Advisors's BlackRock Health Sciences Trust position peaked at $221K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2022.

Based on Claro Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.